Cargando…
Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma
Adrenocortical carcinoma (ACC) is a rare malignancy with an overall unfavorable prognosis. Clinicians treating patients with ACC have noted accelerated growth in metastatic liver lesions that requires rapid intervention compared to other metastatic locations. This study measured and compared the gro...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628706/ https://www.ncbi.nlm.nih.gov/pubmed/34898541 http://dx.doi.org/10.3390/curroncol28060370 |
_version_ | 1784607051494719488 |
---|---|
author | Fuller, Sarah N. Shafiei, Ahmad Venzon, David J. Liewehr, David J. Mauda Havanuk, Michal Ilanchezhian, Maran G. Edgerly, Maureen Anderson, Victoria L. Levy, Elliot B. Hoang, Choung D. Jones, Elizabeth C. Reilly, Karlyne M. Widemann, Brigitte C. Wood, Bradford J. Bagheri, Hadi Del Rivero, Jaydira |
author_facet | Fuller, Sarah N. Shafiei, Ahmad Venzon, David J. Liewehr, David J. Mauda Havanuk, Michal Ilanchezhian, Maran G. Edgerly, Maureen Anderson, Victoria L. Levy, Elliot B. Hoang, Choung D. Jones, Elizabeth C. Reilly, Karlyne M. Widemann, Brigitte C. Wood, Bradford J. Bagheri, Hadi Del Rivero, Jaydira |
author_sort | Fuller, Sarah N. |
collection | PubMed |
description | Adrenocortical carcinoma (ACC) is a rare malignancy with an overall unfavorable prognosis. Clinicians treating patients with ACC have noted accelerated growth in metastatic liver lesions that requires rapid intervention compared to other metastatic locations. This study measured and compared the growth rates of metastatic ACC lesions in the lungs, liver, and lymph nodes using volumetric segmentation. A total of 12 patients with metastatic ACC (six male; six female) were selected based on their medical history. Computer tomography (CT) exams were retrospectively reviewed and a sampling of ≤5 metastatic lesions per organ were selected for evaluation. Lesions in the liver, lung, and lymph nodes were measured and evaluated by volumetric segmentation. Statistical analyses were performed to compare the volumetric growth rates of the lesions in each organ system. In this cohort, 5/12 had liver lesions, 7/12 had lung lesions, and 5/12 had lymph node lesions. A total of 92 lesions were evaluated and segmented for lesion volumetry. The volume doubling time per organ system was 27 days in the liver, 90 days in the lungs, and 95 days in the lymph nodes. In this series of 12 patients with metastatic ACC, liver lesions showed a faster growth rate than lung or lymph node lesions. |
format | Online Article Text |
id | pubmed-8628706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86287062021-11-30 Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma Fuller, Sarah N. Shafiei, Ahmad Venzon, David J. Liewehr, David J. Mauda Havanuk, Michal Ilanchezhian, Maran G. Edgerly, Maureen Anderson, Victoria L. Levy, Elliot B. Hoang, Choung D. Jones, Elizabeth C. Reilly, Karlyne M. Widemann, Brigitte C. Wood, Bradford J. Bagheri, Hadi Del Rivero, Jaydira Curr Oncol Article Adrenocortical carcinoma (ACC) is a rare malignancy with an overall unfavorable prognosis. Clinicians treating patients with ACC have noted accelerated growth in metastatic liver lesions that requires rapid intervention compared to other metastatic locations. This study measured and compared the growth rates of metastatic ACC lesions in the lungs, liver, and lymph nodes using volumetric segmentation. A total of 12 patients with metastatic ACC (six male; six female) were selected based on their medical history. Computer tomography (CT) exams were retrospectively reviewed and a sampling of ≤5 metastatic lesions per organ were selected for evaluation. Lesions in the liver, lung, and lymph nodes were measured and evaluated by volumetric segmentation. Statistical analyses were performed to compare the volumetric growth rates of the lesions in each organ system. In this cohort, 5/12 had liver lesions, 7/12 had lung lesions, and 5/12 had lymph node lesions. A total of 92 lesions were evaluated and segmented for lesion volumetry. The volume doubling time per organ system was 27 days in the liver, 90 days in the lungs, and 95 days in the lymph nodes. In this series of 12 patients with metastatic ACC, liver lesions showed a faster growth rate than lung or lymph node lesions. MDPI 2021-11-01 /pmc/articles/PMC8628706/ /pubmed/34898541 http://dx.doi.org/10.3390/curroncol28060370 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fuller, Sarah N. Shafiei, Ahmad Venzon, David J. Liewehr, David J. Mauda Havanuk, Michal Ilanchezhian, Maran G. Edgerly, Maureen Anderson, Victoria L. Levy, Elliot B. Hoang, Choung D. Jones, Elizabeth C. Reilly, Karlyne M. Widemann, Brigitte C. Wood, Bradford J. Bagheri, Hadi Del Rivero, Jaydira Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma |
title | Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma |
title_full | Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma |
title_fullStr | Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma |
title_full_unstemmed | Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma |
title_short | Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma |
title_sort | tumor doubling time using ct volumetric segmentation in metastatic adrenocortical carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628706/ https://www.ncbi.nlm.nih.gov/pubmed/34898541 http://dx.doi.org/10.3390/curroncol28060370 |
work_keys_str_mv | AT fullersarahn tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT shafieiahmad tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT venzondavidj tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT liewehrdavidj tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT maudahavanukmichal tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT ilanchezhianmarang tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT edgerlymaureen tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT andersonvictorial tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT levyelliotb tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT hoangchoungd tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT joneselizabethc tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT reillykarlynem tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT widemannbrigittec tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT woodbradfordj tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT bagherihadi tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma AT delriverojaydira tumordoublingtimeusingctvolumetricsegmentationinmetastaticadrenocorticalcarcinoma |